{"ticker": {"uuid": "d9197c4e-b923-4fa4-8b19-e13ac315e099", "symbol": "S1RP34", "name": "Sarepta Therapeutics, Inc.", "exchange": "SAO", "country": "BR", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "FDA Gives Sarepta Green Light to Restart Shipment of DMD Gene Therapy Elevidys to Patients Who Are Ambulatory", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNZ0ZVa25ob0M3amlQZ01LTUtTUnM0MExnZmFmNnZGVVMydE83T0dybjdudzZHZmZJdEhXcWdYVUVpWjJKMDRTQTJQUWNPT3NSNVN2aWpWeEJ2Z1BVSVRTbXllb2hXTVczRlM3Z2FXR3VYRTUwU201a0g0bzZ5NWh0V3llSVoxRmtwVkwwTmphSTMwcnlJS2dFYWd4eEFoNVQ0Q0V5VWpyazBiY0tXX2ZSaG1IUnZQYUtMemNLTkFn?oc=5", "source_name": "CGTLive\u00ae", "published_at": "2025-07-30T07:00:00+00:00", "published_display": "30 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Sarepta Stock Jump 20% On Tuesday? Here\u2019s What JPMorgan, Bernstein, Barclays Said About Elevidys", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOTmJLdXRqQ3JuejRqZTNobEs4MWtPN2lidlJZa3B1dUh0dzI2ZHJTY29nanBlbXdZeUtMZFp4aU4wV255ZnczQVltUEF5R1Z6Y2ZHckpqX1E2S2E1UGhxZ3I3Y05IaV9SWjBYWG9yWWF2M3NhQlA3S2JYcHM2Z3d0bVZ6amMzUDgzcXRFMHNnMHFwWU9QRk81WFF1ZDRNU05VUG9WUW01QzNQWHRKS1lqUzI5dk8?oc=5", "source_name": "Stocktwits", "published_at": "2025-07-29T18:52:31+00:00", "published_display": "29 Jul 2025 18:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta Stock On the Rise Following Resumption of Elevidys Shipments in US", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPZ1lLTTNuV1ZUNmZYd1VYYUgzQlBCdUNieWhGcThHNEdKbndYRmVNLXR4cGpUQ0xUbVhUdmN3S0xQdk1xd3lzYWlUS3Q2MU1uanpSODloLXNmVEdQcmNReW5mYkplMEJwck01Z2EzUXBmWWRVSEljS29NOFZKMjM1Qnc1ZDlIMHdRTEE?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches Probe", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQNUM3NEhvb25HWEZWU0lncUNQNm0yUjV1V0hra3lJMmxxVWRjWGFZQjVuU081Z0laSXpLWXNXZzNqX19ZZzZ1SUNmSnlfeHltWjlBS0V4TEdPWF9ITGNDTXByMkNlaUFPdEJJbEFyZ3Nwbmh5cVdrMUR2dnRDdHNJaTE2QkRpM1ljTThHM1R6YXgtdlBNYWdoZ08tX09UTVN0dEdUUmRNZVRaRUhPUUxV?oc=5", "source_name": "BioSpace", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Informs Sarepta That It Recommends That Sarepta Remove Its Pause and Resume Shipments of ELEVIDYS for Ambulatory Individuals With Duchenne Muscular Dystrophy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNdHZ4U0pCNlBIdnZseGtfS3ozOU1faWpoOUdsLTNraFVmUldvZHM2d3lRT0hTdEFvQVJ0NFA2el9tbFB3b19YeFZySmZ1N2dTTU8zMHpfMWRwN09xN3lRQ3pNQ1ptWDVCb2g1aU5OckVYREkzQnVpaG91UVJOYTRWMFNFT05xaG1VV1d5Z3lsWU1SN1hCc0xURTd5bGktR0xsMGhTbWJONjRBSko5Y0dVSFVTc1JSN3FNbnVWMndnb0N5TWJ2SWIycG5McUNhZ1R6?oc=5", "source_name": "Sarepta Therapeutics", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Death of Patient Treated With Sarepta\u2019s Elevidys Being Investigated by FDA, but Company Claims it is Unrelated to the Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQMG1JMGdRVlFEV01yclhZN29ORXliOTN6dTJ1QW1PWW03ZHVmU2pNLTYzcHE2cThjSEtLUkd2WDZCS05wdjRFUG5qb3JLQnE4ZjM1azFoLUlWQnJQeUQ0aGNMZE04OWdWWGxxbDhJWjNIVHJSUWxyN3Nrc3VhRDB0cWhDZDhIVkhfS0RLZ2I5X2NBcV81OERyZnkwT1BiV3lyazNLSnlKWlVMUGhBNDNMQ25EbEczX2o3RHNUX3hmenRHX3B4dVE?oc=5", "source_name": "CGTLive\u00ae", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOQkdrWmhqOE4yOFJaT043N3VsRHA3Sk52aDN1SUV0S2JsSENENDR4S0Zaa2tmS2ItYXg2bW5pMkM3N094UWZ6UHEwNmRUOThIM1pYMTJtN254djZPRVV6eUJsUFA4aWRBd0lZMjNtZ2ZZTlp4MFFJX1pieUJkT204U0hHU0NzcTdtdnEzNWhNZkdSS05oaTlxM05zeERndnNScU5wVzBCWHVPQ0NCX2hJOXlpWjlWdU40VzFadjlpZWpRSHR0Z2tGR0M0RDM?oc=5", "source_name": "Sarepta Therapeutics", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOcnYyOERGcEd3UGVKYmR6UmR6OHV3LS1tRm5HVVRwLXB6QXhmWnpfWnp2YTllSHo2RnNnZVlFbG1vNHM1aGFDNFNiaENTWE9XdURCVFhDS0FkVW1DdHZDSGJHcUk0X0lyS1lHVkdhMFFJbkVPTTVSTlhwSXI5djJGeXUtTTlVTVNucUZoRkpQa1hqWUVpQ25sc3RuSF9nd0N2aGJ1YTVFWkFMNXV2SHl4SGJJdS1UZlJGbTNvZm1mZXl6TmY1SV9leWtLVDFzM1hrU1BkZkpfSmQySk5rZUx1QjQzbw?oc=5", "source_name": "Reuters", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Investigates Death of Boy Who Got Sarepta\u2019s Gene Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQdEctdzZkdVlVZ25yOUY2WV9WWV9LU2JCX0F4bl8tZjM5enFEU0lYclVwNml3dlctVDBDZElobFpPZG1DcjVPREpmVWdWNXNOd3h3NlltamRGeG1jMW01NVUyRHRMYUFNTk9BM1lsNDFQb3MzSmN6bEo1dk5uUER6SmxTWFRNSjFPU3hfTnpwWkxhS2h1WHMyWHBTUF9xQ0x4czhWdUstTWJMcG8xNEozVA?oc=5", "source_name": "Bloomberg", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta shares slump after third patient death this year", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNQ1JCTm5OcW1tQ0gweFhfa2ZnVy1xamNGV2tPSmM2bmI2QU1YYjFMeEVkU01MM0ZPd3hmT203VXp6OXBkRFlCck5YLTlnSXNxRXJjNkNlNGJqUnptS0g3R1dCTzFwRUFkczZ5TXpGbW1DcWFVTnlpVzJnekdEeGJzWDM4QnkxSEtrYmZzX2tGM2UwellaZlhPQkQ1Rzd5UUZ2WXV5S1pkcmVzQnltM0czdXl3ZHBFSWxVdzltMkVxSzM1M1JxSVkw?oc=5", "source_name": "Reuters", "published_at": "2025-07-18T07:00:00+00:00", "published_display": "18 Jul 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "FDA Gives Sarepta Green Light to Restart Shipment of DMD Gene Therapy Elevidys to Patients Who Are Ambulatory", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNZ0ZVa25ob0M3amlQZ01LTUtTUnM0MExnZmFmNnZGVVMydE83T0dybjdudzZHZmZJdEhXcWdYVUVpWjJKMDRTQTJQUWNPT3NSNVN2aWpWeEJ2Z1BVSVRTbXllb2hXTVczRlM3Z2FXR3VYRTUwU201a0g0bzZ5NWh0V3llSVoxRmtwVkwwTmphSTMwcnlJS2dFYWd4eEFoNVQ0Q0V5VWpyazBiY0tXX2ZSaG1IUnZQYUtMemNLTkFn?oc=5", "source_name": "CGTLive\u00ae", "published_at": "2025-07-30T07:00:00+00:00", "published_display": "30 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Sarepta Stock Jump 20% On Tuesday? Here\u2019s What JPMorgan, Bernstein, Barclays Said About Elevidys", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOTmJLdXRqQ3JuejRqZTNobEs4MWtPN2lidlJZa3B1dUh0dzI2ZHJTY29nanBlbXdZeUtMZFp4aU4wV255ZnczQVltUEF5R1Z6Y2ZHckpqX1E2S2E1UGhxZ3I3Y05IaV9SWjBYWG9yWWF2M3NhQlA3S2JYcHM2Z3d0bVZ6amMzUDgzcXRFMHNnMHFwWU9QRk81WFF1ZDRNU05VUG9WUW01QzNQWHRKS1lqUzI5dk8?oc=5", "source_name": "Stocktwits", "published_at": "2025-07-29T18:52:31+00:00", "published_display": "29 Jul 2025 18:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta Stock On the Rise Following Resumption of Elevidys Shipments in US", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPZ1lLTTNuV1ZUNmZYd1VYYUgzQlBCdUNieWhGcThHNEdKbndYRmVNLXR4cGpUQ0xUbVhUdmN3S0xQdk1xd3lzYWlUS3Q2MU1uanpSODloLXNmVEdQcmNReW5mYkplMEJwck01Z2EzUXBmWWRVSEljS29NOFZKMjM1Qnc1ZDlIMHdRTEE?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches Probe", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQNUM3NEhvb25HWEZWU0lncUNQNm0yUjV1V0hra3lJMmxxVWRjWGFZQjVuU081Z0laSXpLWXNXZzNqX19ZZzZ1SUNmSnlfeHltWjlBS0V4TEdPWF9ITGNDTXByMkNlaUFPdEJJbEFyZ3Nwbmh5cVdrMUR2dnRDdHNJaTE2QkRpM1ljTThHM1R6YXgtdlBNYWdoZ08tX09UTVN0dEdUUmRNZVRaRUhPUUxV?oc=5", "source_name": "BioSpace", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Informs Sarepta That It Recommends That Sarepta Remove Its Pause and Resume Shipments of ELEVIDYS for Ambulatory Individuals With Duchenne Muscular Dystrophy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxNdHZ4U0pCNlBIdnZseGtfS3ozOU1faWpoOUdsLTNraFVmUldvZHM2d3lRT0hTdEFvQVJ0NFA2el9tbFB3b19YeFZySmZ1N2dTTU8zMHpfMWRwN09xN3lRQ3pNQ1ptWDVCb2g1aU5OckVYREkzQnVpaG91UVJOYTRWMFNFT05xaG1VV1d5Z3lsWU1SN1hCc0xURTd5bGktR0xsMGhTbWJONjRBSko5Y0dVSFVTc1JSN3FNbnVWMndnb0N5TWJ2SWIycG5McUNhZ1R6?oc=5", "source_name": "Sarepta Therapeutics", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "New Death of Patient Treated With Sarepta\u2019s Elevidys Being Investigated by FDA, but Company Claims it is Unrelated to the Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMixgFBVV95cUxQMG1JMGdRVlFEV01yclhZN29ORXliOTN6dTJ1QW1PWW03ZHVmU2pNLTYzcHE2cThjSEtLUkd2WDZCS05wdjRFUG5qb3JLQnE4ZjM1azFoLUlWQnJQeUQ0aGNMZE04OWdWWGxxbDhJWjNIVHJSUWxyN3Nrc3VhRDB0cWhDZDhIVkhfS0RLZ2I5X2NBcV81OERyZnkwT1BiV3lyazNLSnlKWlVMUGhBNDNMQ25EbEczX2o3RHNUX3hmenRHX3B4dVE?oc=5", "source_name": "CGTLive\u00ae", "published_at": "2025-07-28T07:00:00+00:00", "published_display": "28 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxOQkdrWmhqOE4yOFJaT043N3VsRHA3Sk52aDN1SUV0S2JsSENENDR4S0Zaa2tmS2ItYXg2bW5pMkM3N094UWZ6UHEwNmRUOThIM1pYMTJtN254djZPRVV6eUJsUFA4aWRBd0lZMjNtZ2ZZTlp4MFFJX1pieUJkT204U0hHU0NzcTdtdnEzNWhNZkdSS05oaTlxM05zeERndnNScU5wVzBCWHVPQ0NCX2hJOXlpWjlWdU40VzFadjlpZWpRSHR0Z2tGR0M0RDM?oc=5", "source_name": "Sarepta Therapeutics", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA probes death of patient on Sarepta's Elevidys, partner Roche says death unrelated to therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxOcnYyOERGcEd3UGVKYmR6UmR6OHV3LS1tRm5HVVRwLXB6QXhmWnpfWnp2YTllSHo2RnNnZVlFbG1vNHM1aGFDNFNiaENTWE9XdURCVFhDS0FkVW1DdHZDSGJHcUk0X0lyS1lHVkdhMFFJbkVPTTVSTlhwSXI5djJGeXUtTTlVTVNucUZoRkpQa1hqWUVpQ25sc3RuSF9nd0N2aGJ1YTVFWkFMNXV2SHl4SGJJdS1UZlJGbTNvZm1mZXl6TmY1SV9leWtLVDFzM1hrU1BkZkpfSmQySk5rZUx1QjQzbw?oc=5", "source_name": "Reuters", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FDA Investigates Death of Boy Who Got Sarepta\u2019s Gene Therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQdEctdzZkdVlVZ25yOUY2WV9WWV9LU2JCX0F4bl8tZjM5enFEU0lYclVwNml3dlctVDBDZElobFpPZG1DcjVPREpmVWdWNXNOd3h3NlltamRGeG1jMW01NVUyRHRMYUFNTk9BM1lsNDFQb3MzSmN6bEo1dk5uUER6SmxTWFRNSjFPU3hfTnpwWkxhS2h1WHMyWHBTUF9xQ0x4czhWdUstTWJMcG8xNEozVA?oc=5", "source_name": "Bloomberg", "published_at": "2025-07-25T07:00:00+00:00", "published_display": "25 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sarepta shares slump after third patient death this year", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNQ1JCTm5OcW1tQ0gweFhfa2ZnVy1xamNGV2tPSmM2bmI2QU1YYjFMeEVkU01MM0ZPd3hmT203VXp6OXBkRFlCck5YLTlnSXNxRXJjNkNlNGJqUnptS0g3R1dCTzFwRUFkczZ5TXpGbW1DcWFVTnlpVzJnekdEeGJzWDM4QnkxSEtrYmZzX2tGM2UwellaZlhPQkQ1Rzd5UUZ2WXV5S1pkcmVzQnltM0czdXl3ZHBFSWxVdzltMkVxSzM1M1JxSVkw?oc=5", "source_name": "Reuters", "published_at": "2025-07-18T07:00:00+00:00", "published_display": "18 Jul 2025 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 60, "total_relevant": 10, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 9, "score": 48, "total": 10, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 92, "events": [{"event": "general", "label": "Market update", "weight": 6.0, "count": 9}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 4.58, "latest_week": "2026-06-19", "one_week_move": 18.3, "four_week_move": 6.8, "twelve_week_move": -12.3, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.101823, "market_dynamics_buy_signal": false, "relative_strength": -15.118889, "fair_value_gap": -78.7, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.8036, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+18.3% over one week, +6.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "CGTLive\u00ae", "count": 2}, {"label": "Sarepta Therapeutics", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "Stocktwits", "count": 1}, {"label": "Pharmaceutical Executive", "count": 1}, {"label": "BioSpace", "count": 1}, {"label": "Bloomberg", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 10}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 9}, {"label": "Regulatory and legal", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "92/100 classification confidence."}, {"label": "Company focus", "value": "10", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+18.3% over one week, +6.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "FDA Gives Sarepta Green Light to Restart Shipment of DMD Gene Therapy Elevidys to Patients Who Are Ambulatory"}], "updated_at": "2026-06-23T00:06:25.357343+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}